GlassScriptPhysician profile
John Symington
NPI 1144253238
$781.46
in general payments reported to CMS, 2019-2025
8 companies · $355 in 2025
The $355 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.62 · 2021: $48.45 · 2023: $78.87 · 2024: $209 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437 · Education: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.02 |
| Education | $205.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $272.94 | 2021-2025 | Biktarvy |
| Shionogi INC | $204.70 | 2025 | Fetroja |
| Merck Sharp & Dohme LLC | $94.87 | 2023-2025 | Pifeltro, Delstrigo, Capvaxive |
| Janssen Biotech, INC. | $66.71 | 2019 | |
| Viiv Healthcare Company | $57.07 | 2019-2021 | |
| Abbvie INC. | $34.96 | 2024 | |
| Insmed, INC. | $27.44 | 2025 | Arikayce |
| Paratek Pharmaceuticals, INC. | $22.77 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Symington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.